Data / Drug companies / Niacinamide
Niacinamide: 5 companies and 16 products in the FDA NDC directory
Niacinamide is listed in the FDA National Drug Code Directory by 5 companies, with 16 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are liquid; cream; emulsion, and the newest product started marketing on July 30, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 5
- Products
- 16
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Topical, Cutaneous, Vaginal
- Brand names
- Derladie Laboratoire Pore Tightening Ampoule, Dr.Jucre Rebirth Booster, Sferangs Vita C Capsulebooster, The Skin House Vital BrightEmulsion, The Skin House Vital Bright EyeCream, The Skin House Vital BrightSerum, Pugan Vegan White Tomato Formula Cleansing Gel, Dr.Jucre Rebirth Eye
- openFDA record search
- api.fda.gov
Companies that list niacinamide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Noksibcho Cosmetic Co., Ltd. | 8 | liquid; cream | Other unapproved drugs | July 1, 2021 |
| Laon Commerce Co LTD | 3 | liquid; gel | Other unapproved drugs | January 1, 2024 |
| Naturecell Co., LTD. | 3 | liquid; cream | Other unapproved drugs | November 30, 2024 |
| Guangzhou Yanhou Cosmetics Co., Ltd. | 1 | emulsion | Over the counter monograph drugs | July 30, 2025 |
| Shengnan (Guangzhou) Cosmetics Co., LTD | 1 | cream | Over the counter monograph drugs | January 6, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 6 | 37.5% |
| Cream | 5 | 31.2% |
| Emulsion | 3 | 18.8% |
| Gel | 2 | 12.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 14 | 87.5% |
| Over the counter monograph drugs | 2 | 12.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Adenosine Receptor Agonist | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.